75D30124Q77727_QandA.docx

DOCX document 16 KB Posted

Attached to
Pre- and Post- Influenza Human Sera Panels Federal contract opportunity
Solicitation number
75D30124Q77727
Issued by
Department of Health and Human Services Centers for Disease Control and Prevention Office of Acquisition Services

About this file

This document is a set of Questions and Answers (Q&A) related to Solicitation # 75D30124Q77727 for Pre- and Post-Influenza Human Sera Panels. The solicitation is seeking the provision of anonymous serum samples from six age cohorts to test for vaccine-induced antibodies against newly circulating influenza virus strains.

The Q&A addresses one key question regarding the type of influenza vaccine that can be used for the young pediatric participants (ages 6 months to 35 months) if the current licensed trivalent seasonal egg-based influenza vaccine is not available. The answer states that the cell-based influenza vaccine is acceptable and the preferred vaccine for the base year. Larger volume serum samples from some adult participants are also required for further testing.

View the file

Other files for this federal contract opportunity

Other files attached to Pre- and Post- Influenza Human Sera Panels, newest first.
File Type Posted
Amendment_00001_RFQ_75D30124Q777727.pdf PDF
A19_SF1449 - POST.docx DOCX document
A19_Combined SynSol_Post_Final.docx DOCX document

On GovTribe

Work with this file on GovTribe

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Pre and post Influenza Human Sera Panels Solicitation # 75D30124Q77727 Questions

1. If the current licensed trivalent seasonal egg-based influenza vaccine is not available to meet the necessary first year timeline, what other vaccines will be acceptable for the young pediatric participants (age 6 months to 35 months)?

ANSWER: Page 18 of the solicitation states that, “This cohort must receive the current licensed seasonal cell-based and /or egg-based influenza vaccine, or other vaccine type as specified by CDC.” The cell-based influenza vaccine is available for 6 month - 35 months pediatric participants and is acceptable. This is the vaccine that will need to be used and is the preferred vaccine in the base year.

File details come from the government source that posted it. Updated .